Safety, Tolerability and Pharmacokinetics of Efavirenz in HIV-Infected Children
Clinical trial NCT00364793 · COMPLETED
Trial details
- NCT number
- NCT00364793
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-02-01
- Primary completion
- 2011-12-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.